Virtual Medicinal Product (VMP)
-
Tetracosactide 1mg/1ml suspension for injection ampoules
Name Details
Current Name
Tetracosactide 1mg/1ml suspension for injection ampoules
|
Start Date
28-06-2004
|
End Date
|
Previous Name
Tetracosactide 1mg/ml injection 1ml ampoules
|
Start Date
18-02-2003
|
End Date
27-06-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Suspension for injection
- Ontology Form/Route
- suspensioninjection.intramuscular
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
H01AA02
BNF |
Current BNF
06050100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06050100
|
Start Date
24-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
3909111000001109 |
18-02-2003 |
|
VMP Ingredients
Name
Tetracosactide acetate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Tetracosactide
-
VMP
(Current) Tetracosactide 1mg/1ml suspension fo...
Virtual Medicinal Product Pack (VMPP) Information